MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder
•MOG antibody disease is the most recent antigen specific autoimmune disease on the NMO Spectrum.•MOG antibody disease is characterized by optic neuritis and less commonly transverse myelitis with generally better outcomes compared to the AQP4 NMO.•Half of MOG antibody positive cases remain monophas...
Saved in:
| Published in | Multiple sclerosis and related disorders Vol. 25; pp. 66 - 72 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.10.2018
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2211-0348 2211-0356 2211-0356 |
| DOI | 10.1016/j.msard.2018.07.025 |
Cover
| Abstract | •MOG antibody disease is the most recent antigen specific autoimmune disease on the NMO Spectrum.•MOG antibody disease is characterized by optic neuritis and less commonly transverse myelitis with generally better outcomes compared to the AQP4 NMO.•Half of MOG antibody positive cases remain monophasic after the initial attack.
MOG antibody disease is an autoimmune disease of the central nervous system associated with a serological antibody against MOG, myelin oligodendrocyte glycoprotein. MOG is a glycoprotein expressed on the outer membrane of myelin and solely found within the central nervous system, including in the brain, optic nerves and spinal cord. Clinically, the disease resembles neuromyelitis optica spectrum disorders in the predilection for relapses of optic neuritis and transverse myelitis. In addition, acute disseminated encephalomyelitis (ADEM) is a well-recognized phenotype of MOG antibody disease in children. In recent studies around the world where MOG testing is available, up to 42% of NMOSD patients who test seronegative for the AQP4 antibody test positive for MOG antibodies. MOG antibody disease has thus recently emerged as a distinct entity carved out of the patient population diagnosed with NMOSD. In this review, we examine the history of the MOG antibody and its relevance to demyelinating disease, as well as compare the clinical, radiographic and serological profiles of patients with MOG antibody with patients with AQP4 antibody. |
|---|---|
| AbstractList | •MOG antibody disease is the most recent antigen specific autoimmune disease on the NMO Spectrum.•MOG antibody disease is characterized by optic neuritis and less commonly transverse myelitis with generally better outcomes compared to the AQP4 NMO.•Half of MOG antibody positive cases remain monophasic after the initial attack.
MOG antibody disease is an autoimmune disease of the central nervous system associated with a serological antibody against MOG, myelin oligodendrocyte glycoprotein. MOG is a glycoprotein expressed on the outer membrane of myelin and solely found within the central nervous system, including in the brain, optic nerves and spinal cord. Clinically, the disease resembles neuromyelitis optica spectrum disorders in the predilection for relapses of optic neuritis and transverse myelitis. In addition, acute disseminated encephalomyelitis (ADEM) is a well-recognized phenotype of MOG antibody disease in children. In recent studies around the world where MOG testing is available, up to 42% of NMOSD patients who test seronegative for the AQP4 antibody test positive for MOG antibodies. MOG antibody disease has thus recently emerged as a distinct entity carved out of the patient population diagnosed with NMOSD. In this review, we examine the history of the MOG antibody and its relevance to demyelinating disease, as well as compare the clinical, radiographic and serological profiles of patients with MOG antibody with patients with AQP4 antibody. Highlights•MOG antibody disease is the most recent antigen specific autoimmune disease on the NMO Spectrum. •MOG antibody disease is characterized by optic neuritis and less commonly transverse myelitis with generally better outcomes compared to the AQP4 NMO. •Half of MOG antibody positive cases remain monophasic after the initial attack. MOG antibody disease is an autoimmune disease of the central nervous system associated with a serological antibody against MOG, myelin oligodendrocyte glycoprotein. MOG is a glycoprotein expressed on the outer membrane of myelin and solely found within the central nervous system, including in the brain, optic nerves and spinal cord. Clinically, the disease resembles neuromyelitis optica spectrum disorders in the predilection for relapses of optic neuritis and transverse myelitis. In addition, acute disseminated encephalomyelitis (ADEM) is a well-recognized phenotype of MOG antibody disease in children. In recent studies around the world where MOG testing is available, up to 42% of NMOSD patients who test seronegative for the AQP4 antibody test positive for MOG antibodies. MOG antibody disease has thus recently emerged as a distinct entity carved out of the patient population diagnosed with NMOSD. In this review, we examine the history of the MOG antibody and its relevance to demyelinating disease, as well as compare the clinical, radiographic and serological profiles of patients with MOG antibody with patients with AQP4 antibody.MOG antibody disease is an autoimmune disease of the central nervous system associated with a serological antibody against MOG, myelin oligodendrocyte glycoprotein. MOG is a glycoprotein expressed on the outer membrane of myelin and solely found within the central nervous system, including in the brain, optic nerves and spinal cord. Clinically, the disease resembles neuromyelitis optica spectrum disorders in the predilection for relapses of optic neuritis and transverse myelitis. In addition, acute disseminated encephalomyelitis (ADEM) is a well-recognized phenotype of MOG antibody disease in children. In recent studies around the world where MOG testing is available, up to 42% of NMOSD patients who test seronegative for the AQP4 antibody test positive for MOG antibodies. MOG antibody disease has thus recently emerged as a distinct entity carved out of the patient population diagnosed with NMOSD. In this review, we examine the history of the MOG antibody and its relevance to demyelinating disease, as well as compare the clinical, radiographic and serological profiles of patients with MOG antibody with patients with AQP4 antibody. MOG antibody disease is an autoimmune disease of the central nervous system associated with a serological antibody against MOG, myelin oligodendrocyte glycoprotein. MOG is a glycoprotein expressed on the outer membrane of myelin and solely found within the central nervous system, including in the brain, optic nerves and spinal cord. Clinically, the disease resembles neuromyelitis optica spectrum disorders in the predilection for relapses of optic neuritis and transverse myelitis. In addition, acute disseminated encephalomyelitis (ADEM) is a well-recognized phenotype of MOG antibody disease in children. In recent studies around the world where MOG testing is available, up to 42% of NMOSD patients who test seronegative for the AQP4 antibody test positive for MOG antibodies. MOG antibody disease has thus recently emerged as a distinct entity carved out of the patient population diagnosed with NMOSD. In this review, we examine the history of the MOG antibody and its relevance to demyelinating disease, as well as compare the clinical, radiographic and serological profiles of patients with MOG antibody with patients with AQP4 antibody. |
| Author | Narayan, Ram Simpson, Alexandra Pardo, Santiago Levy, Michael Fritsche, Katelyn Paul, Friedemann Salama, Sara Mealy, Maureen |
| Author_xml | – sequence: 1 givenname: Ram surname: Narayan fullname: Narayan, Ram organization: Department of Neurology, Johns Hopkins University, Baltimore, MD, USA – sequence: 2 givenname: Alexandra surname: Simpson fullname: Simpson, Alexandra organization: Department of Neurology, Johns Hopkins University, Baltimore, MD, USA – sequence: 3 givenname: Katelyn surname: Fritsche fullname: Fritsche, Katelyn organization: Department of Neurology, Johns Hopkins University, Baltimore, MD, USA – sequence: 4 givenname: Sara orcidid: 0000-0003-2380-8152 surname: Salama fullname: Salama, Sara organization: Department of Neurology, Johns Hopkins University, Baltimore, MD, USA – sequence: 5 givenname: Santiago surname: Pardo fullname: Pardo, Santiago organization: Department of Neurology, Johns Hopkins University, Baltimore, MD, USA – sequence: 6 givenname: Maureen orcidid: 0000-0001-8967-6338 surname: Mealy fullname: Mealy, Maureen organization: Department of Neurology, Johns Hopkins University, Baltimore, MD, USA – sequence: 7 givenname: Friedemann surname: Paul fullname: Paul, Friedemann organization: Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, NeuroCure Clinical Research Center, Berlin, Germany – sequence: 8 givenname: Michael orcidid: 0000-0002-7969-8346 surname: Levy fullname: Levy, Michael email: mlevy@jhmi.edu organization: Department of Neurology, Johns Hopkins University, Baltimore, MD, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30048919$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl1rFDEYhYNU2lr7CwTJpTc75mMzk1EslGKr0NKL2uuQSd5A1plkTGYq--_NuG3BgmxuksB5Tsg57xt0EGIAhN5RUlFC64-basg62YoRKivSVISJV-iYMUpXhIv64Pm8lkfoNOcNKasWdF3TQ3TECVnLlrbHqLu5vcI6TL6Ldoutz6AzfMLnOMGDh984OvyPIkOKY8x-8g-AA8wpDlvoyzXjOE7eaJxHMFOah8UsJgvpLXrtdJ_h9HE_QfeXX39cfFtd3159vzi_XhnB2bRqCQPbQNs555hx1Mmu5hYEtZJy0TnNuKmZsVy72ojGmI43nJFyLH_kIPgJ-rDzHVP8NUOe1OCzgb7XAeKcFSONFJLJNS_S94_SuRvAqjH5QaetesqlCPhOYFLMOYF7llCilgLURv0tQC0FKNKoUkCh2heU8ZOefAxT0r7fw37ZsVAiKtEnlY2HYMD6VAJVNvo9_NkL3vQ-lEL6n7CFvIlzCiV9RVVmiqi7ZTyW6aCSE8ZrUgw-_99g7_N_AAocy-Y |
| CitedBy_id | crossref_primary_10_1097_APO_0000000000000513 crossref_primary_10_1111_ncn3_12547 crossref_primary_10_2217_fnl_2018_0032 crossref_primary_10_3389_fneur_2020_525933 crossref_primary_10_3389_fneur_2020_00778 crossref_primary_10_18231_j_ijn_2024_041 crossref_primary_10_1007_s00415_024_12438_6 crossref_primary_10_1016_j_jocn_2020_11_011 crossref_primary_10_1111_ceo_13863 crossref_primary_10_1186_s12974_019_1674_2 crossref_primary_10_1016_j_aopr_2022_100064 crossref_primary_10_1136_bcr_2020_238992 crossref_primary_10_1016_j_msard_2020_102156 crossref_primary_10_1016_j_jneuroim_2020_577389 crossref_primary_10_3174_ajnr_A8045 crossref_primary_10_4103_jpn_jpn_238_20 crossref_primary_10_3390_biomedicines7020042 crossref_primary_10_3389_fimmu_2021_625465 crossref_primary_10_1055_s_0041_1725152 crossref_primary_10_1080_14728214_2020_1803828 crossref_primary_10_1007_s42451_019_0081_3 crossref_primary_10_1136_jnnp_2022_330714 crossref_primary_10_1016_j_msard_2020_102428 crossref_primary_10_4236_ojoph_2022_121001 crossref_primary_10_1007_s00415_020_09755_x crossref_primary_10_1016_j_jocn_2022_05_002 crossref_primary_10_2174_1570159X18666200429010825 crossref_primary_10_1016_j_msard_2020_102265 crossref_primary_10_30629_2658_7947_2024_29_6_51_55 crossref_primary_10_5692_clinicalneurol_cn_001389 crossref_primary_10_1016_j_msard_2020_102142 crossref_primary_10_1186_s12883_021_02133_8 crossref_primary_10_1007_s10876_023_02518_4 crossref_primary_10_1016_j_msard_2019_01_021 crossref_primary_10_1177_1352458520968820 crossref_primary_10_1016_j_neurad_2019_06_001 crossref_primary_10_1016_j_tig_2023_02_003 crossref_primary_10_1186_s12883_022_02612_6 crossref_primary_10_1007_s00115_021_01092_2 crossref_primary_10_1136_jnnp_2020_324422 crossref_primary_10_1136_jnnp_2021_327412 crossref_primary_10_1080_00207454_2020_1720676 crossref_primary_10_1016_j_msard_2022_103746 crossref_primary_10_1016_j_imbio_2020_151959 crossref_primary_10_1016_j_msard_2020_102729 crossref_primary_10_1136_jim_2019_001126 crossref_primary_10_3390_life12040488 crossref_primary_10_1136_practneurol_2020_002830 crossref_primary_10_17116_jnevro202012007213 crossref_primary_10_17116_jnevro202112107196 crossref_primary_10_3174_ajnr_A6003 crossref_primary_10_1080_14656566_2018_1540592 crossref_primary_10_1016_j_msard_2019_02_023 crossref_primary_10_1016_j_msard_2020_102579 crossref_primary_10_1177_1352458518815596 crossref_primary_10_1055_s_0043_1767713 crossref_primary_10_1136_pn_2022_003560 crossref_primary_10_1016_j_msard_2020_102696 crossref_primary_10_1177_1352458519841824 crossref_primary_10_1177_11795735231167869 crossref_primary_10_1177_17562864211014389 crossref_primary_10_1016_S1474_4422_20_30392_6 crossref_primary_10_1080_08820538_2020_1866027 crossref_primary_10_12786_bn_2022_15_e9 crossref_primary_10_1016_j_msard_2021_103030 crossref_primary_10_1038_s41467_020_16625_7 crossref_primary_10_1111_cei_13641 crossref_primary_10_3389_fneur_2021_775181 crossref_primary_10_1016_j_expneurol_2020_113486 crossref_primary_10_1080_23279095_2023_2210242 crossref_primary_10_1002_brb3_1842 crossref_primary_10_1038_s41598_024_83760_2 crossref_primary_10_3389_fneur_2019_00608 crossref_primary_10_1016_j_oftal_2019_11_011 crossref_primary_10_3390_molecules27113516 crossref_primary_10_3389_fneur_2020_499910 crossref_primary_10_1136_bcr_2018_227435 crossref_primary_10_17650_2073_8803_2023_18_1_10_21 crossref_primary_10_1080_14737175_2021_1982697 crossref_primary_10_1515_hsz_2021_0122 crossref_primary_10_3389_fnhum_2021_782490 crossref_primary_10_1007_s40259_020_00460_9 crossref_primary_10_1016_j_clinbiochem_2021_10_004 crossref_primary_10_1016_j_msard_2018_09_027 crossref_primary_10_1016_j_oftale_2019_11_008 crossref_primary_10_1111_nan_12574 crossref_primary_10_1136_postgradmedj_2020_138472 crossref_primary_10_2147_IMCRJ_S459799 crossref_primary_10_1080_14712598_2021_1884223 crossref_primary_10_3389_fimmu_2021_642272 crossref_primary_10_3390_biomedicines8040071 crossref_primary_10_12677_ACM_2022_123335 crossref_primary_10_1016_j_msard_2019_101488 crossref_primary_10_1016_j_ajem_2023_04_031 crossref_primary_10_1212_WNL_0000000000011154 crossref_primary_10_4103_aian_aian_860_21 crossref_primary_10_17650_2073_8803_2021_16_3_21_33 crossref_primary_10_1016_j_jns_2019_07_014 crossref_primary_10_3389_fimmu_2018_02753 crossref_primary_10_3389_fneur_2020_00501 crossref_primary_10_1007_s00415_021_10764_7 crossref_primary_10_1177_1756286420947977 crossref_primary_10_1111_ene_14414 crossref_primary_10_1007_s00415_019_09206_2 crossref_primary_10_2214_AJR_20_24061 crossref_primary_10_3389_fneur_2021_635419 crossref_primary_10_1007_s11940_021_00672_6 crossref_primary_10_25259_KPJ_31_2023 crossref_primary_10_1155_2018_8487471 crossref_primary_10_3389_fimmu_2023_1129906 crossref_primary_10_1155_2018_5381239 crossref_primary_10_1016_j_msard_2020_102108 crossref_primary_10_37871_jbres1423 crossref_primary_10_1111_jon_13175 crossref_primary_10_1172_jci_insight_165373 crossref_primary_10_3389_fneur_2023_1102353 crossref_primary_10_1016_j_ajoc_2021_101060 crossref_primary_10_1016_j_msard_2020_102342 crossref_primary_10_1186_s12974_019_1521_5 crossref_primary_10_1016_j_nerep_2021_100041 crossref_primary_10_1097_WNO_0000000000001537 crossref_primary_10_1007_s00281_018_0723_8 crossref_primary_10_1007_s10072_020_04828_1 crossref_primary_10_3345_cep_2019_01305 crossref_primary_10_1080_14712598_2020_1749259 crossref_primary_10_1016_j_msard_2019_101907 crossref_primary_10_3389_fnagi_2022_850743 crossref_primary_10_1080_09273948_2020_1860231 crossref_primary_10_1016_j_msard_2020_102538 crossref_primary_10_1016_j_msard_2020_101965 crossref_primary_10_7759_cureus_23877 crossref_primary_10_1080_14737175_2019_1559051 crossref_primary_10_3389_fneur_2018_00888 crossref_primary_10_1016_j_braindev_2019_06_004 crossref_primary_10_1016_j_msard_2020_102376 crossref_primary_10_1016_j_nerep_2022_100073 crossref_primary_10_1136_bmjopen_2019_035397 crossref_primary_10_3389_fped_2020_00339 crossref_primary_10_1007_s11910_023_01287_x crossref_primary_10_1002_jnr_25054 crossref_primary_10_1016_j_msard_2021_103356 crossref_primary_10_2147_ITT_S255722 crossref_primary_10_1016_j_msard_2022_103531 crossref_primary_10_1177_2324709620976018 crossref_primary_10_1038_s41572_018_0041_4 crossref_primary_10_1186_s13256_023_04191_7 crossref_primary_10_1007_s40120_023_00474_9 crossref_primary_10_1093_clinchem_hvac061 crossref_primary_10_1177_1352458519837705 crossref_primary_10_1007_s10072_023_06853_2 crossref_primary_10_1111_cen3_12623 crossref_primary_10_3389_fneur_2020_00450 |
| Cites_doi | 10.1155/2012/460825 10.1191/1352458505ms1187sr 10.1212/NXI.0000000000000163 10.1590/0004-282X20140032 10.1007/s00415-017-8596-7 10.1177/1352458512466317 10.1212/NXI.0000000000000400 10.1212/NXI.0000000000000012 10.1186/s12974-018-1144-2 10.1056/NEJMoa063602 10.1212/01.WNL.0000127615.15768.AE 10.1001/archneurol.2011.154 10.1212/WNL.0b013e318248dec1 10.1212/NXI.0000000000000175 10.1136/jnnp-2017-315998 10.1186/1742-2094-8-184 10.1136/jnnp-2014-308346 10.1111/j.1471-4159.1989.tb10930.x 10.1212/NXI.0000000000000225 10.1007/s00415-017-8635-4 10.1016/B978-0-444-63432-0.00006-2 10.1186/s12974-016-0718-0 10.1212/01.wnl.0000303817.82134.da 10.1016/j.jneuroim.2010.02.007 10.1136/jnnp-2016-314005 10.1002/mus.24298 10.1177/1352458515593406 10.1212/NXI.0000000000000040 10.1056/NEJMoa022328 10.1001/jamaneurol.2017.4601 10.1177/1352458515591069 10.1371/journal.pone.0170847 10.1212/NXI.0000000000000089 10.1212/WNL.0000000000001729 10.1186/1742-2094-9-14 10.1093/brain/aww350 10.1212/WNL.0000000000000101 10.1212/WNL.0000000000001367 10.1212/NXI.0000000000000110 10.1186/s12974-016-0720-6 10.1186/s12974-016-0717-1 10.1001/jamaneurol.2017.3196 10.1136/jnnp-2014-310206 10.1212/WNL.0b013e318228c0b1 10.1177/1352458515622986 10.1001/jamaneurol.2013.5857 10.1136/jnnp-2015-312676 10.1001/jamaneurol.2013.3890 10.1212/NXI.0000000000000412 10.1212/NXI.0000000000000131 10.1212/NXI.0000000000000062 10.1073/pnas.90.17.7990 10.1038/sj.sc.3101758 10.1136/jnnp-2017-316880 10.1212/NXI.0000000000000257 10.1002/acn3.164 10.1038/ncpneuro0764 10.1002/ana.21916 10.1177/1352458513507822 10.1177/1352458516678474 10.1212/NXI.0000000000000322 10.1093/brain/awx276 10.1111/ene.12058 10.1007/s00401-013-1116-7 10.1002/ana.20770 10.1046/j.1471-4159.1999.0720001.x 10.1001/archneurol.2011.2956 10.1186/s12974-016-0719-z 10.1007/s00415-016-8333-7 10.1038/nm1488 10.1212/WNL.0000000000002844 10.3109/01658107.2015.1084332 10.3389/fimmu.2017.00529 10.1093/brain/122.11.2047 |
| ContentType | Journal Article |
| Copyright | 2018 Elsevier B.V. Elsevier B.V. Copyright © 2018 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2018 Elsevier B.V. – notice: Elsevier B.V. – notice: Copyright © 2018 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.msard.2018.07.025 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2211-0356 |
| EndPage | 72 |
| ExternalDocumentID | 30048919 10_1016_j_msard_2018_07_025 S2211034818302360 1_s2_0_S2211034818302360 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1P~ 1~. 1~5 4.4 457 4G. 53G 5VS 7-5 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABGSF ABJNI ABMAC ABMZM ABTEW ABUDA ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGWIK AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV EBS EFJIC EFKBS EJD FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HZ~ KOM M41 MO0 MOBAO O-L O9- OAUVE OP~ P-8 P-9 PC. Q38 ROL SDF SEL SPCBC SSH SSN SSU SSZ T5K Z5R ~G- AACTN AFKWA AJOXV AMFUW RIG AADPK AAIAV ABLVK ABYKQ AJBFU DOVZS EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 ACLOT ~HD |
| ID | FETCH-LOGICAL-c532t-902ed7e9bfff2cf1f8b63de51d8135bfa23c62cd3af6c57ccb37320c573483e53 |
| IEDL.DBID | AIKHN |
| ISSN | 2211-0348 2211-0356 |
| IngestDate | Sat Sep 27 18:30:58 EDT 2025 Wed Feb 19 02:34:05 EST 2025 Tue Jul 01 04:16:23 EDT 2025 Thu Apr 24 22:55:14 EDT 2025 Fri Feb 23 02:11:25 EST 2024 Sun Feb 23 10:18:50 EST 2025 Tue Aug 26 20:07:29 EDT 2025 |
| IsPeerReviewed | false |
| IsScholarly | true |
| Language | English |
| License | Copyright © 2018 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c532t-902ed7e9bfff2cf1f8b63de51d8135bfa23c62cd3af6c57ccb37320c573483e53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0001-8967-6338 0000-0003-2380-8152 0000-0002-7969-8346 |
| PMID | 30048919 |
| PQID | 2078582843 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_2078582843 pubmed_primary_30048919 crossref_primary_10_1016_j_msard_2018_07_025 crossref_citationtrail_10_1016_j_msard_2018_07_025 elsevier_sciencedirect_doi_10_1016_j_msard_2018_07_025 elsevier_clinicalkeyesjournals_1_s2_0_S2211034818302360 elsevier_clinicalkey_doi_10_1016_j_msard_2018_07_025 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-10-01 |
| PublicationDateYYYYMMDD | 2018-10-01 |
| PublicationDate_xml | – month: 10 year: 2018 text: 2018-10-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Multiple sclerosis and related disorders |
| PublicationTitleAlternate | Mult Scler Relat Disord |
| PublicationYear | 2018 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Kitley, Waters, Woodhall, Leite, Murchison, George, Kuker, Chandratre, Vincent, Palace (bib0033) 2014; 71 Weinshenker, Wingerchuk, Vukusic, Linbo, Pittock, Lucchinetti, Lennon (bib0075) 2006; 59 Oh, Levy (bib0050) 2012; 2012 Baumann, Sahin, Lechner, Hennes, Schanda, Mader, Karenfort, Selch, Hausler, Eisenkolbl, Salandin, Gruber-Sedlmayr, Blaschek, Kraus, Leiz, Finsterwalder, Gotwald, Kuchukhidze, Berger, Reindl, Rostasy (bib0002) 2015; 86 Huppke, Rostasy, Karenfort, Huppke, Seidl, Leiz, Reindl, Gartner (bib0015) 2013; 19 Jarius, Ruprecht, Wildemann, Kuempfel, Ringelstein, Geis, Kleiter, Kleinschnitz, Berthele, Brettschneider, Hellwig, Hemmer, Linker, Lauda, Mayer, Tumani, Melms, Trebst, Stangel, Marziniak, Hoffmann, Schippling, Faiss, Neuhaus, Ettrich, Zentner, Guthke, Hofstadt-van Oy, Reuss, Pellkofer, Ziemann, Kern, Wandinger, Bergh, Boettcher, Langel, Liebetrau, Rommer, Niehaus, Munch, Winkelmann, Zettl, Metz, Veauthier, Sieb, Wilke, Hartung, Aktas, Paul (bib0022) 2012; 9 Ogawa, Nakashima, Takahashi, Kaneko, Akaishi, Takai, Sato, Nishiyama, Misu, Kuroda, Aoki, Fujihara (bib0049) 2017; 4 Jurynczyk, Geraldes, Probert, Woodhall, Waters, Tackley, DeLuca, Chandratre, Leite, Vincent, Palace (bib0025) 2017; 140 Moura, Sato, Rimkus, Apostolos-Pereira, de Oliveira, Leite, Fujihara, Monteiro, Callegaro (bib0046) 2015; 39 Zekeridou, Lennon (bib0078) 2015; 2 Kitley, Leite, Kuker, Quaghebeur, George, Waters, Woodhall, Vincent, Palace (bib0032) 2013; 70 Spadaro, Gerdes, Krumbholz, Ertl-Wagner, Thaler, Schuh, Metz, Blaschek, Dick, Bruck, Hohlfeld, Meinl, Kumpfel (bib0068) 2016; 3 Kuhle, Pohl, Mehling, Edan, Freedman, Hartung, Polman, Miller, Montalban, Barkhof, Bauer, Dahms, Lindberg, Kappos, Sandbrink (bib0036) 2007; 356 Spadaro, Gerdes, Mayer, Ertl-Wagner, Laurent, Krumbholz, Breithaupt, Hogen, Straube, Giese, Hohlfeld, Lassmann, Meinl, Kumpfel (bib0069) 2015; 2 Jurynczyk, Tackley, Kong, Geraldes, Matthews, Woodhall, Waters, Kuker, Craner, Weir, DeLuca, Kremer, Leite, Vincent, Jacob, de Seze, Palace (bib0027) 2017; 88 Probstel, Dornmair, Bittner, Sperl, Jenne, Magalhaes, Villalobos, Breithaupt, Weissert, Jacob, Krumbholz, Kuempfel, Blaschek, Stark, Gartner, Pohl, Rostasy, Weber, Forne, Khademi, Olsson, Brilot, Tantsis, Dale, Wekerle, Hohlfeld, Banwell, Bar-Or, Meinl, Derfuss (bib0058) 2011; 77 Wang, Jaunmuktane, Mummery, Brandner, Leary, Trip (bib0072) 2016; 87 Kremer, Mealy, Jacob, Nakashima, Cabre, Bigi, Paul, Jarius, Aktas, Elsone, Mutch, Levy, Takai, Collongues, Banwell, Fujihara, de Seze (bib0035) 2014; 20 Pearce (bib0053) 2005; 43 Waters, McKeon, Leite, Rajasekharan, Lennon, Villalobos, Palace, Mandrekar, Vincent, Bar-Or, Pittock (bib0074) 2012; 78 Kiyat-Atamer, Ekizoglu, Tuzun, Kurtuncu, Shugaiv, Akman-Demir, Eraksoy (bib0034) 2013; 20 Ramanathan, Mohammad, Tantsis, Nguyen, Merheb, Fung, White, Broadley, Lechner-Scott, Vucic, Henderson, Barnett, Reddel, Brilot, Dale (bib0059) 2018; 89 Peschl, Bradl, Hoftberger, Berger, Reindl (bib0055) 2017; 8 Jarius, Paul, Franciotta, Waters, Zipp, Hohlfeld, Vincent, Wildemann (bib0019) 2008; 4 Kim, Woodhall, Kim, Kim, Park, Vincent, Lee, Waters (bib0031) 2015; 2 Kaneko, Sato, Nakashima, Nishiyama, Tanaka, Marignier, Hyun, Oliveira, Reindl, Seifert-Held, Sepulveda, Siritho, Waters, Kurosawa, Akaishi, Kuroda, Misu, Prayoonwiwat, Berger, Saiz, Kim, Nomura, Callegaro, Fujihara, Aoki (bib0028) 2016; 87 Waters, Woodhall, O'Connor, Reindl, Lang, Sato, Jurynczyk, Tackley, Rocha, Takahashi, Misu, Nakashima, Palace, Fujihara, Leite, Vincent (bib0073) 2015; 2 Kim, Kim, Li, Jung, Kim (bib0030) 2011; 68 Berger, Rubner, Schautzer, Egg, Ulmer, Mayringer, Dilitz, Deisenhammer, Reindl (bib0003) 2003; 349 Johns, Bernard (bib0024) 1999; 72 Pandit, Mustafa, Uppoor, Nakashima, Takahashi, Kaneko (bib0052) 2018; 5 Malik, Lewis, Cree, Ratelade, Rossi, Verkman, Bollen, Ralph (bib0040) 2014; 50 Pache, Zimmermann, Mikolajczak, Schumacher, Lacheta, Oertel, Bellmann-Strobl, Jarius, Wildemann, Reindl, Waldman, Soelberg, Asgari, Ringelstein, Aktas, Gross, Buttmann, Ach, Ruprecht, Paul, Brandt (bib0051) 2016; 13 Jarius, Ruprecht, Kleiter, Borisow, Asgari, Pitarokoili, Pache, Stich, Beume, Hummert, Trebst, Ringelstein, Aktas, Winkelmann, Buttmann, Schwarz, Zimmermann, Brandt, Franciotta, Capobianco, Kuchling, Haas, Korporal-Kuhnke, Lillevang, Fechner, Schanda, Paul, Wildemann, Reindl (bib0021) 2016; 13 Pekcevik, Mitchell, Mealy, Orman, Lee, Newsome, Thompson, Pardo, Calabresi, Levy, Izbudak (bib0054) 2016; 22 Di Pauli, Hoftberger, Reindl, Beer, Rhomberg, Schanda, Sato, Fujihara, Lassmann, Schmutzhard, Berger (bib0009) 2015; 2 Hacohen, Wong, Lechner, Jurynczyk, Wright, Konuskan, Kalser, Poulat, Maurey, Ganelin-Cohen, Wassmer, Hemingway, Forsyth, Hennes, Leite, Ciccarelli, Anlar, Hintzen, Marignier, Palace, Baumann, Rostasy, Neuteboom, Deiva, Lim (bib0010) 2018; 75 Misu, Hoftberger, Fujihara, Wimmer, Takai, Nishiyama, Nakashima, Konno, Bradl, Garzuly, Itoyama, Aoki, Lassmann (bib0044) 2013; 125 Brunner, Lassmann, Waehneldt, Matthieu, Linington (bib0005) 1989; 52 Hamid, Whittam, Saviour, Alorainy, Mutch, Linaker, Solomon, Bhojak, Woodhall, Waters, Appleton, Duddy, Jacob (bib0013) 2018; 75 Zamvil, Slavin (bib0077) 2015; 2 Mealy, Kim, Schmidt, Lopez, Jimenez Arango, Paul, D.M., B.M., Kim, Levy (bib0043) 2017 Sato, Callegaro, Lana-Peixoto, Nakashima, Fujihara (bib0065) 2014; 72 Saini, Fernandez, Kerr, Levy (bib0064) 2010; 221 Matiello, Lennon, Jacob, Pittock, Lucchinetti, Wingerchuk, Weinshenker (bib0042) 2008; 70 Hamid, Whittam, Mutch, Linaker, Solomon, Das, Bhojak, Jacob (bib0012) 2017; 264 Kim, Paul, Lana-Peixoto, Tenembaum, Asgari, Palace, Klawiter, Sato, de Seze, Wuerfel, Banwell, Villoslada, Saiz, Fujihara, Kim (bib0029) 2015; 84 Lim, Berger, Reindl, Dalton, Fernando, Keir, Thompson, Miller, Giovannoni (bib0038) 2005; 11 Mader, Gredler, Schanda, Rostasy, Dujmovic, Pfaller, Lutterotti, Jarius, Di Pauli, Kuenz, Ehling, Hegen, Deisenhammer, Aboul-Enein, Storch, Koson, Drulovic, Kristoferitsch, Berger, Reindl (bib0039) 2011; 8 Ramanathan, Prelog, Barnes, Tantsis, Reddel, Henderson, Vucic, Gorman, Benson, Alper, Riney, Barnett, Parratt, Hardy, Leventer, Merheb, Nosadini, Fung, Brilot, Dale (bib0060) 2016; 22 Jarius, Metz, Konig, Ruprecht, Reindl, Paul, Bruck, Wildemann (bib0018) 2016; 22 Chalmoukou, Alexopoulos, Akrivou, Stathopoulos, Reindl, Dalakas (bib0006) 2015; 2 Sato, Callegaro, Lana-Peixoto, Waters, de Haidar Jorge, Takahashi, Nakashima, Apostolos-Pereira, Talim, Simm, Lino, Misu, Leite, Aoki, Fujihara (bib0066) 2014; 82 Montcuquet, Collongues, Papeix, Zephir, Audoin, Laplaud, Bourre, Brochet, Camdessanche, Labauge, Moreau, Brassat, Stankoff, de Seze, Vukusic, Marignier (bib0045) 2017; 23 Jurynczyk, Messina, Woodhall, Raza, Everett, Roca-Fernandez, Tackley, Hamid, Sheard, Reynolds, Chandratre, Hemingway, Jacob, Vincent, Leite, Waters, Palace (bib0026) 2017; 140 Havla, Kumpfel, Schinner, Spadaro, Schuh, Meinl, Hohlfeld, Outteryck (bib0014) 2017; 264 Mariotto, Ferrari, Monaco, Benedetti, Schanda, Alberti, Farinazzo, Capra, Mancinelli, De Rossi, Bombardi, Zuliani, Zoccarato, Tanel, Bonora, Turatti, Calabrese, Polo, Pavone, Grazian, Sechi, Sechi, Urso, Delogu, Janes, Deotto, Cadaldini, Bianchi, Cantalupo, Reindl, Gajofatto (bib0041) 2017; 264 Brilot, Dale, Selter, Grummel, Kalluri, Aslam, Busch, Zhou, Cepok, Hemmer (bib0004) 2009; 66 Wingerchuk, Banwell, Bennett, Cabre, Carroll, Chitnis, de Seze, Fujihara, Greenberg, Jacob, Jarius, Lana-Peixoto, Levy, Simon, Tenembaum, Traboulsee, Waters, Wellik, Weinshenker (bib0076) 2015; 85 Reindl, Linington, Brehm, Egg, Dilitz, Deisenhammer, Poewe, Berger (bib0062) 1999; 122 Dale, Tantsis, Merheb, Kumaran, Sinmaz, Pathmanandavel, Ramanathan, Booth, Wienholt, Prelog, Clark, Guillemin, Lim, Mathey, Brilot (bib0008) 2014; 1 Chen, Zhang, Lian, Liu, Shi, Miao, Feng, Du, Xie, Yao, Zhou (bib0007) 2017; 4 Ramanathan, Reddel, Henderson, Parratt, Barnett, Gatt, Merheb, Kumaran, Pathmanandavel, Sinmaz, Ghadiri, Yiannikas, Vucic, Stewart, Bleasel, Booth, Fung, Dale, Brilot (bib0061) 2014; 1 Stiebel-Kalish, Lotan, Brody, Chodick, Bialer, Marignier, Bach, Hellmann (bib0071) 2017; 12 Huppke, Rostasy, Karenfort, Huppke, Seidl, Leiz, Reindl, Gartner (bib0011) 2013; 19 Lampasona, Franciotta, Furlan, Zanaboni, Fazio, Bonifacio, Comi, Martino (bib0037) 2004; 62 Stefferl, Brehm, Linington (bib0070) 2000 Pham-Dinh, Mattei, Nussbaum, Roussel, Pontarotti, Roeckel, Mather, Artzt, Lindahl, Dautigny (bib0056) 1993; 90 Jarius, Kleiter, Ruprecht, Asgari, Pitarokoili, Borisow, Hummert, Trebst, Pache, Winkelmann, Beume, Ringelstein, Stich, Aktas, Korporal-Kuhnke, Schwarz, Lukas, Haas, Fechner, Buttmann, Bellmann-Strobl, Zimmermann, Brandt, Franciotta, Schanda, Paul, Reindl, Wildemann (bib0017) 2016; 13 Akaishi, Sato, Nakashima, Takeshita, Takahashi, Doi, Kurosawa, Kaneko, Kuroda, Nishiyama, Misu, Nakazawa, Fujihara, Aoki (bib0001) 2016; 87 Jarius, Ruprecht, Kleiter, Borisow, Asgari, Pitarokoili, Pache, Stich, Beume, Hummert, Ringelstein, Trebst, Winkelmann, Schwarz, Buttmann, Zimmermann, Kuchling, Franciotta, Capobianco, Siebert, Lukas, Korporal-Kuhnke, Haas, Fechner, Brandt, Schanda, Aktas, Paul, Reindl, Wildemann (bib0020) 2016; 13 Jarius, Paul, Aktas, Asgari, Dale, de Seze, Franciotta, Fujihara, Jacob, Kim, Kleiter, Kümpfel, Levy, Palace, Ruprecht, Saiz, Trebst, Weinshenker, Wildemann (bib0023) 2018; 15 Hyun, Woodhall, Kim, Jeong, Kong, Kim, Kim, Park, Irani, Waters, Kim (bib0016) 2017; 88 Rostasy, Mader, Schanda, Huppke, Gartner, Kraus, Karenfort, Tibussek, Blaschek, Bajer-Kornek, Leitz, Schimmel, Di Pauli, Berger, Reindl (bib0063) 2012; 69 O'Connor, McLaughlin, De Jager, Chitnis, Bettelli, Xu, Robinson, Cherry, Bar-Or, Banwell, Fukaura, Fukazawa, Tenembaum, Wong, Tavakoli, Idrissova, Viglietta, Rostasy, Pohl, Dale, Freedman, Steinman, Buckle, Kuchroo, Hafler, Wucherpfennig (bib0047) 2007; 13 Popescu, Lucchinetti (bib0057) 2016; 133 Sepulveda, Armangue, Sola-Valls, Arrambide, Meca-Lallana, Oreja-Guevara, Mendibe, Alvarez de Arcaya, Aladro, Casanova, Olascoaga, Jimenez-Huete, Jurynczyk (10.1016/j.msard.2018.07.025_bib0026) 2017; 140 Sato (10.1016/j.msard.2018.07.025_bib0065) 2014; 72 Ramanathan (10.1016/j.msard.2018.07.025_bib0061) 2014; 1 Baumann (10.1016/j.msard.2018.07.025_bib0002) 2015; 86 Brilot (10.1016/j.msard.2018.07.025_bib0004) 2009; 66 Matiello (10.1016/j.msard.2018.07.025_bib0042) 2008; 70 Ramanathan (10.1016/j.msard.2018.07.025_bib0059) 2018; 89 Kiyat-Atamer (10.1016/j.msard.2018.07.025_bib0034) 2013; 20 Weinshenker (10.1016/j.msard.2018.07.025_bib0075) 2006; 59 Kitley (10.1016/j.msard.2018.07.025_bib0032) 2013; 70 Mader (10.1016/j.msard.2018.07.025_bib0039) 2011; 8 Jarius (10.1016/j.msard.2018.07.025_bib0022) 2012; 9 Sato (10.1016/j.msard.2018.07.025_bib0066) 2014; 82 Wang (10.1016/j.msard.2018.07.025_bib0072) 2016; 87 Peschl (10.1016/j.msard.2018.07.025_bib0055) 2017; 8 Havla (10.1016/j.msard.2018.07.025_bib0014) 2017; 264 Waters (10.1016/j.msard.2018.07.025_bib0074) 2012; 78 Brunner (10.1016/j.msard.2018.07.025_bib0005) 1989; 52 Moura (10.1016/j.msard.2018.07.025_bib0046) 2015; 39 Rostasy (10.1016/j.msard.2018.07.025_bib0063) 2012; 69 Montcuquet (10.1016/j.msard.2018.07.025_bib0045) 2017; 23 Pache (10.1016/j.msard.2018.07.025_bib0051) 2016; 13 Pekcevik (10.1016/j.msard.2018.07.025_bib0054) 2016; 22 Oh (10.1016/j.msard.2018.07.025_bib0050) 2012; 2012 O'Connor (10.1016/j.msard.2018.07.025_bib0047) 2007; 13 Jarius (10.1016/j.msard.2018.07.025_bib0023) 2018; 15 Chalmoukou (10.1016/j.msard.2018.07.025_bib0006) 2015; 2 Ogawa (10.1016/j.msard.2018.07.025_bib0049) 2017; 4 Pham-Dinh (10.1016/j.msard.2018.07.025_bib0056) 1993; 90 Reindl (10.1016/j.msard.2018.07.025_bib0062) 1999; 122 Huppke (10.1016/j.msard.2018.07.025_bib0015) 2013; 19 Mealy (10.1016/j.msard.2018.07.025_bib0043) 2017 Kuhle (10.1016/j.msard.2018.07.025_bib0036) 2007; 356 Jurynczyk (10.1016/j.msard.2018.07.025_bib0025) 2017; 140 Hyun (10.1016/j.msard.2018.07.025_bib0016) 2017; 88 Lampasona (10.1016/j.msard.2018.07.025_bib0037) 2004; 62 Kremer (10.1016/j.msard.2018.07.025_bib0035) 2014; 20 Stefferl (10.1016/j.msard.2018.07.025_bib0070) 2000 Hamid (10.1016/j.msard.2018.07.025_bib0013) 2018; 75 Kim (10.1016/j.msard.2018.07.025_bib0030) 2011; 68 Probstel (10.1016/j.msard.2018.07.025_bib0058) 2011; 77 Ramanathan (10.1016/j.msard.2018.07.025_bib0060) 2016; 22 Wingerchuk (10.1016/j.msard.2018.07.025_bib0076) 2015; 85 Hacohen (10.1016/j.msard.2018.07.025_bib0010) 2018; 75 Kaneko (10.1016/j.msard.2018.07.025_bib0028) 2016; 87 Jarius (10.1016/j.msard.2018.07.025_bib0017) 2016; 13 Jarius (10.1016/j.msard.2018.07.025_bib0021) 2016; 13 Kitley (10.1016/j.msard.2018.07.025_bib0033) 2014; 71 Jarius (10.1016/j.msard.2018.07.025_bib0018) 2016; 22 Zamvil (10.1016/j.msard.2018.07.025_bib0077) 2015; 2 Huppke (10.1016/j.msard.2018.07.025_bib0011) 2013; 19 Pearce (10.1016/j.msard.2018.07.025_bib0053) 2005; 43 Dale (10.1016/j.msard.2018.07.025_bib0008) 2014; 1 Misu (10.1016/j.msard.2018.07.025_bib0044) 2013; 125 Stiebel-Kalish (10.1016/j.msard.2018.07.025_bib0071) 2017; 12 Jarius (10.1016/j.msard.2018.07.025_bib0019) 2008; 4 Johns (10.1016/j.msard.2018.07.025_bib0024) 1999; 72 Chen (10.1016/j.msard.2018.07.025_bib0007) 2017; 4 Berger (10.1016/j.msard.2018.07.025_bib0003) 2003; 349 Di Pauli (10.1016/j.msard.2018.07.025_bib0009) 2015; 2 Spadaro (10.1016/j.msard.2018.07.025_bib0068) 2016; 3 Hamid (10.1016/j.msard.2018.07.025_bib0012) 2017; 264 Sepulveda (10.1016/j.msard.2018.07.025_bib0067) 2016; 3 Jarius (10.1016/j.msard.2018.07.025_bib0020) 2016; 13 Waters (10.1016/j.msard.2018.07.025_bib0073) 2015; 2 Zekeridou (10.1016/j.msard.2018.07.025_bib0078) 2015; 2 Spadaro (10.1016/j.msard.2018.07.025_bib0069) 2015; 2 Kim (10.1016/j.msard.2018.07.025_bib0031) 2015; 2 Malik (10.1016/j.msard.2018.07.025_bib0040) 2014; 50 Popescu (10.1016/j.msard.2018.07.025_bib0057) 2016; 133 Pandit (10.1016/j.msard.2018.07.025_bib0052) 2018; 5 Kim (10.1016/j.msard.2018.07.025_bib0029) 2015; 84 Akaishi (10.1016/j.msard.2018.07.025_bib0001) 2016; 87 Lim (10.1016/j.msard.2018.07.025_bib0038) 2005; 11 Mariotto (10.1016/j.msard.2018.07.025_bib0041) 2017; 264 Saini (10.1016/j.msard.2018.07.025_bib0064) 2010; 221 Jurynczyk (10.1016/j.msard.2018.07.025_bib0027) 2017; 88 30384960 - Mult Scler Relat Disord. 2018 Oct;25:A1-A2 |
| References_xml | – volume: 69 start-page: 752 year: 2012 end-page: 756 ident: bib0063 article-title: Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis publication-title: Arch. Neurol. – volume: 264 start-page: 139 year: 2017 end-page: 151 ident: bib0014 article-title: Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration publication-title: J. Neurol. – volume: 2 start-page: e62 year: 2015 ident: bib0077 article-title: Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 22 start-page: 302 year: 2016 end-page: 311 ident: bib0054 article-title: Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging publication-title: Multiple Scler. – volume: 88 start-page: 811 year: 2017 end-page: 817 ident: bib0016 article-title: Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 8 start-page: 184 year: 2011 ident: bib0039 article-title: Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders publication-title: J. Neuroinflamm. – volume: 23 start-page: 1377 year: 2017 end-page: 1384 ident: bib0045 article-title: Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders publication-title: Multiple Scler. – volume: 4 start-page: 202 year: 2008 end-page: 214 ident: bib0019 article-title: Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica publication-title: Nat. Clin. Pract. Neurol. – volume: 349 start-page: 139 year: 2003 end-page: 145 ident: bib0003 article-title: Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event publication-title: N. Engl. J. Med. – volume: 22 start-page: 470 year: 2016 end-page: 482 ident: bib0060 article-title: Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis publication-title: Multiple Scler. – volume: 85 start-page: 177 year: 2015 end-page: 189 ident: bib0076 article-title: International consensus diagnostic criteria for neuromyelitis optica spectrum disorders publication-title: Neurology – volume: 62 start-page: 2092 year: 2004 end-page: 2094 ident: bib0037 article-title: Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects publication-title: Neurology – year: 2017 ident: bib0043 article-title: Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders publication-title: Multiple Scler. – volume: 2 start-page: 295 year: 2015 end-page: 301 ident: bib0069 article-title: Histopathology and clinical course of MOG-antibody-associated encephalomyelitis publication-title: Ann. Clin. Trans. Neurol. – volume: 66 start-page: 833 year: 2009 end-page: 842 ident: bib0004 article-title: Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease publication-title: Ann. Neurol. – volume: 20 start-page: 843 year: 2014 end-page: 847 ident: bib0035 article-title: Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients publication-title: Multiple Scler. – volume: 39 start-page: 285 year: 2015 end-page: 288 ident: bib0046 article-title: Anti-MOG (myelin oligodendrocyte glycoprotein)-positive severe optic neuritis with optic disc ischaemia and macular star publication-title: Neuroophthalmology – volume: 52 start-page: 296 year: 1989 end-page: 304 ident: bib0005 article-title: Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats publication-title: J. Neurochem. – volume: 3 start-page: e225 year: 2016 ident: bib0067 article-title: Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 2 start-page: e175 year: 2015 ident: bib0009 article-title: Fulminant demyelinating encephalomyelitis: insights from antibody studies and neuropathology publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 50 start-page: 859 year: 2014 end-page: 862 ident: bib0040 article-title: Transient hyperckemia in the setting of neuromyelitis optica (NMO) publication-title: Muscle Nerve – volume: 72 start-page: 445 year: 2014 end-page: 450 ident: bib0065 article-title: Seronegative neuromyelitis optica spectrum–the challenges on disease definition and pathogenesis publication-title: Arq. Neuropsiquiatr. – volume: 90 start-page: 7990 year: 1993 end-page: 7994 ident: bib0056 article-title: Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex publication-title: Proc. Natl. Acad. Sci. USA – volume: 43 start-page: 631 year: 2005 end-page: 634 ident: bib0053 article-title: Neuromyelitis optica publication-title: Spinal Cord – volume: 13 start-page: 282 year: 2016 ident: bib0051 article-title: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients publication-title: J. Neuroinflamm. – volume: 4 start-page: e400 year: 2017 ident: bib0007 article-title: Muscle damage in patients with neuromyelitis optica spectrum disorder publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 8 start-page: 529 year: 2017 ident: bib0055 article-title: Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases publication-title: Front. Immunol. – volume: 82 start-page: 474 year: 2014 end-page: 481 ident: bib0066 article-title: Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders publication-title: Neurology – volume: 71 start-page: 276 year: 2014 end-page: 283 ident: bib0033 article-title: Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study publication-title: JAMA Neurol. – volume: 88 start-page: 132 year: 2017 end-page: 136 ident: bib0027 article-title: Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 13 start-page: 279 year: 2016 ident: bib0021 article-title: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin publication-title: J. Neuroinflamm. – volume: 59 start-page: 566 year: 2006 end-page: 569 ident: bib0075 article-title: Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis publication-title: Ann. Neurol. – volume: 70 start-page: 1375 year: 2013 end-page: 1381 ident: bib0032 article-title: Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies publication-title: JAMA Neurol. – volume: 84 start-page: 1165 year: 2015 end-page: 1173 ident: bib0029 article-title: MRI characteristics of neuromyelitis optica spectrum disorder: an international update publication-title: Neurology – volume: 86 start-page: 265 year: 2015 end-page: 272 ident: bib0002 article-title: Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 2012 year: 2012 ident: bib0050 article-title: Neuromyelitis optica: an antibody-mediated disorder of the central nervous system publication-title: Neurol. Res. Int. – volume: 133 start-page: 95 year: 2016 end-page: 106 ident: bib0057 article-title: Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis publication-title: Handb Clin Neurol – volume: 68 start-page: 1412 year: 2011 end-page: 1420 ident: bib0030 article-title: Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years publication-title: Arch. Neurol. – volume: 87 start-page: 229 year: 2016 end-page: 231 ident: bib0072 article-title: Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD publication-title: Neurology – volume: 19 start-page: 941 year: 2013 end-page: 946 ident: bib0011 article-title: Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients publication-title: Multiple Scler. – volume: 15 start-page: 134 year: 2018 ident: bib0023 article-title: MOG encephalomyelitis: international recommendations on diagnosis and antibody testing publication-title: J. Neuroinflamm. – start-page: 123 year: 2000 end-page: 133 ident: bib0070 article-title: The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis publication-title: J. Neural Transm. Suppl. – volume: 78 start-page: 665 year: 2012 end-page: 671 ident: bib0074 article-title: Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays publication-title: Neurology – volume: 19 start-page: 941 year: 2013 end-page: 946 ident: bib0015 article-title: Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients publication-title: Multiple Scler. – volume: 75 start-page: 65 year: 2018 end-page: 71 ident: bib0013 article-title: Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs. aquaporin 4 IgG disease publication-title: JAMA Neurol. – volume: 221 start-page: 68 year: 2010 end-page: 72 ident: bib0064 article-title: Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity publication-title: J. Neuroimmunol. – volume: 264 start-page: 2088 year: 2017 end-page: 2094 ident: bib0012 article-title: What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients publication-title: J. Neurol. – volume: 140 start-page: 617 year: 2017 end-page: 627 ident: bib0025 article-title: Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis publication-title: Brain – volume: 125 start-page: 815 year: 2013 end-page: 827 ident: bib0044 article-title: Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica publication-title: Acta Neuropathol. – volume: 87 start-page: 446 year: 2016 end-page: 448 ident: bib0001 article-title: MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 122 start-page: 2047 year: 1999 end-page: 2056 ident: bib0062 article-title: Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study publication-title: Brain – volume: 1 start-page: e12 year: 2014 ident: bib0008 article-title: Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 13 start-page: 211 year: 2007 end-page: 217 ident: bib0047 article-title: Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein publication-title: Nat. Med. – volume: 77 start-page: 580 year: 2011 end-page: 588 ident: bib0058 article-title: Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis publication-title: Neurology – volume: 20 start-page: 781 year: 2013 end-page: 787 ident: bib0034 article-title: Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients publication-title: Eur. J. Neurol. – volume: 13 start-page: 280 year: 2016 ident: bib0020 article-title: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome publication-title: J. Neuroinflamm. – volume: 2 start-page: e131 year: 2015 ident: bib0006 article-title: Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 89 start-page: 127 year: 2018 end-page: 137 ident: bib0059 article-title: Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 70 start-page: 2197 year: 2008 end-page: 2200 ident: bib0042 article-title: NMO-IgG predicts the outcome of recurrent optic neuritis publication-title: Neurology – volume: 12 year: 2017 ident: bib0071 article-title: Retinal nerve fiber layer may be better preserved in MOG-IgG versus AQP4-IgG optic neuritis: a cohort study publication-title: PLoS One – volume: 13 start-page: 281 year: 2016 ident: bib0017 article-title: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: brainstem involvement - frequency, presentation and outcome publication-title: J. Neuroinflamm. – volume: 3 start-page: e257 year: 2016 ident: bib0068 article-title: Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 356 start-page: 371 year: 2007 end-page: 378 ident: bib0036 article-title: Lack of association between antimyelin antibodies and progression to multiple sclerosis publication-title: N. Engl. J. Med. – volume: 5 start-page: e412 year: 2018 ident: bib0052 article-title: Reversible paraspinal muscle hyperintensity in anti-MOG antibody-associated transverse myelitis publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 87 start-page: 1257 year: 2016 end-page: 1259 ident: bib0028 article-title: Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies publication-title: J. Neurol. Neurosurg. Psychiatry – volume: 264 start-page: 2420 year: 2017 end-page: 2430 ident: bib0041 article-title: Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study publication-title: J. Neurol. – volume: 1 start-page: e40 year: 2014 ident: bib0061 article-title: Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 11 start-page: 492 year: 2005 end-page: 494 ident: bib0038 article-title: Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis publication-title: Multiple Scler. – volume: 72 start-page: 1 year: 1999 end-page: 9 ident: bib0024 article-title: The structure and function of myelin oligodendrocyte glycoprotein publication-title: J. Neurochem. – volume: 2 start-page: e89 year: 2015 ident: bib0073 article-title: MOG cell-based assay detects non-MS patients with inflammatory neurologic disease publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 2 start-page: e163 year: 2015 ident: bib0031 article-title: Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 75 start-page: 478 year: 2018 end-page: 487 ident: bib0010 article-title: Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease publication-title: JAMA Neurol. – volume: 22 start-page: 1541 year: 2016 end-page: 1549 ident: bib0018 article-title: Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case publication-title: Multiple Scler. – volume: 140 start-page: 3128 year: 2017 end-page: 3138 ident: bib0026 article-title: Clinical presentation and prognosis in MOG-antibody disease: a UK study publication-title: Brain – volume: 4 start-page: e322 year: 2017 ident: bib0049 article-title: MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 9 start-page: 14 year: 2012 ident: bib0022 article-title: Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients publication-title: J. Neuroinflamm. – volume: 2 start-page: e110 year: 2015 ident: bib0078 article-title: Aquaporin-4 autoimmunity publication-title: Neurol. Neuroimmunol. Neuroinflamm. – volume: 2012 year: 2012 ident: 10.1016/j.msard.2018.07.025_bib0050 article-title: Neuromyelitis optica: an antibody-mediated disorder of the central nervous system publication-title: Neurol. Res. Int. doi: 10.1155/2012/460825 – volume: 11 start-page: 492 issue: 4 year: 2005 ident: 10.1016/j.msard.2018.07.025_bib0038 article-title: Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis publication-title: Multiple Scler. doi: 10.1191/1352458505ms1187sr – volume: 2 start-page: e163 issue: 6 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0031 article-title: Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000163 – volume: 72 start-page: 445 issue: 6 year: 2014 ident: 10.1016/j.msard.2018.07.025_bib0065 article-title: Seronegative neuromyelitis optica spectrum–the challenges on disease definition and pathogenesis publication-title: Arq. Neuropsiquiatr. doi: 10.1590/0004-282X20140032 – volume: 264 start-page: 2088 issue: 10 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0012 article-title: What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients publication-title: J. Neurol. doi: 10.1007/s00415-017-8596-7 – volume: 19 start-page: 941 issue: 7 year: 2013 ident: 10.1016/j.msard.2018.07.025_bib0015 article-title: Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients publication-title: Multiple Scler. doi: 10.1177/1352458512466317 – volume: 4 start-page: e400 issue: 6 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0007 article-title: Muscle damage in patients with neuromyelitis optica spectrum disorder publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000400 – volume: 1 start-page: e12 issue: 1 year: 2014 ident: 10.1016/j.msard.2018.07.025_bib0008 article-title: Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000012 – volume: 15 start-page: 134 year: 2018 ident: 10.1016/j.msard.2018.07.025_bib0023 article-title: MOG encephalomyelitis: international recommendations on diagnosis and antibody testing publication-title: J. Neuroinflamm. doi: 10.1186/s12974-018-1144-2 – volume: 356 start-page: 371 issue: 4 year: 2007 ident: 10.1016/j.msard.2018.07.025_bib0036 article-title: Lack of association between antimyelin antibodies and progression to multiple sclerosis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa063602 – start-page: 123 issue: 58 year: 2000 ident: 10.1016/j.msard.2018.07.025_bib0070 article-title: The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis publication-title: J. Neural Transm. Suppl. – volume: 62 start-page: 2092 issue: 11 year: 2004 ident: 10.1016/j.msard.2018.07.025_bib0037 article-title: Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects publication-title: Neurology doi: 10.1212/01.WNL.0000127615.15768.AE – volume: 68 start-page: 1412 issue: 11 year: 2011 ident: 10.1016/j.msard.2018.07.025_bib0030 article-title: Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years publication-title: Arch. Neurol. doi: 10.1001/archneurol.2011.154 – volume: 78 start-page: 665 issue: 9 year: 2012 ident: 10.1016/j.msard.2018.07.025_bib0074 article-title: Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays publication-title: Neurology doi: 10.1212/WNL.0b013e318248dec1 – volume: 2 start-page: e175 issue: 6 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0009 article-title: Fulminant demyelinating encephalomyelitis: insights from antibody studies and neuropathology publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000175 – volume: 88 start-page: 811 issue: 10 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0016 article-title: Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp-2017-315998 – volume: 8 start-page: 184 year: 2011 ident: 10.1016/j.msard.2018.07.025_bib0039 article-title: Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders publication-title: J. Neuroinflamm. doi: 10.1186/1742-2094-8-184 – volume: 86 start-page: 265 issue: 3 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0002 article-title: Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp-2014-308346 – volume: 52 start-page: 296 issue: 1 year: 1989 ident: 10.1016/j.msard.2018.07.025_bib0005 article-title: Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.1989.tb10930.x – volume: 3 start-page: e225 issue: 3 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0067 article-title: Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000225 – volume: 264 start-page: 2420 issue: 12 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0041 article-title: Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study publication-title: J. Neurol. doi: 10.1007/s00415-017-8635-4 – year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0043 article-title: Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders publication-title: Multiple Scler. – volume: 133 start-page: 95 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0057 article-title: Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis publication-title: Handb Clin Neurol doi: 10.1016/B978-0-444-63432-0.00006-2 – volume: 13 start-page: 280 issue: 1 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0020 article-title: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome publication-title: J. Neuroinflamm. doi: 10.1186/s12974-016-0718-0 – volume: 70 start-page: 2197 issue: 23 year: 2008 ident: 10.1016/j.msard.2018.07.025_bib0042 article-title: NMO-IgG predicts the outcome of recurrent optic neuritis publication-title: Neurology doi: 10.1212/01.wnl.0000303817.82134.da – volume: 221 start-page: 68 issue: 1-2 year: 2010 ident: 10.1016/j.msard.2018.07.025_bib0064 article-title: Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity publication-title: J. Neuroimmunol. doi: 10.1016/j.jneuroim.2010.02.007 – volume: 88 start-page: 132 issue: 2 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0027 article-title: Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp-2016-314005 – volume: 50 start-page: 859 issue: 5 year: 2014 ident: 10.1016/j.msard.2018.07.025_bib0040 article-title: Transient hyperckemia in the setting of neuromyelitis optica (NMO) publication-title: Muscle Nerve doi: 10.1002/mus.24298 – volume: 22 start-page: 470 issue: 4 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0060 article-title: Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis publication-title: Multiple Scler. doi: 10.1177/1352458515593406 – volume: 1 start-page: e40 issue: 4 year: 2014 ident: 10.1016/j.msard.2018.07.025_bib0061 article-title: Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000040 – volume: 349 start-page: 139 issue: 2 year: 2003 ident: 10.1016/j.msard.2018.07.025_bib0003 article-title: Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa022328 – volume: 75 start-page: 478 issue: 4 year: 2018 ident: 10.1016/j.msard.2018.07.025_bib0010 article-title: Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2017.4601 – volume: 22 start-page: 302 issue: 3 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0054 article-title: Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging publication-title: Multiple Scler. doi: 10.1177/1352458515591069 – volume: 12 issue: 1 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0071 article-title: Retinal nerve fiber layer may be better preserved in MOG-IgG versus AQP4-IgG optic neuritis: a cohort study publication-title: PLoS One doi: 10.1371/journal.pone.0170847 – volume: 2 start-page: e89 issue: 3 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0073 article-title: MOG cell-based assay detects non-MS patients with inflammatory neurologic disease publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000089 – volume: 85 start-page: 177 issue: 2 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0076 article-title: International consensus diagnostic criteria for neuromyelitis optica spectrum disorders publication-title: Neurology doi: 10.1212/WNL.0000000000001729 – volume: 9 start-page: 14 year: 2012 ident: 10.1016/j.msard.2018.07.025_bib0022 article-title: Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients publication-title: J. Neuroinflamm. doi: 10.1186/1742-2094-9-14 – volume: 140 start-page: 617 issue: 3 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0025 article-title: Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis publication-title: Brain doi: 10.1093/brain/aww350 – volume: 82 start-page: 474 issue: 6 year: 2014 ident: 10.1016/j.msard.2018.07.025_bib0066 article-title: Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders publication-title: Neurology doi: 10.1212/WNL.0000000000000101 – volume: 84 start-page: 1165 issue: 11 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0029 article-title: MRI characteristics of neuromyelitis optica spectrum disorder: an international update publication-title: Neurology doi: 10.1212/WNL.0000000000001367 – volume: 2 start-page: e110 issue: 4 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0078 article-title: Aquaporin-4 autoimmunity publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000110 – volume: 13 start-page: 282 issue: 1 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0051 article-title: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients publication-title: J. Neuroinflamm. doi: 10.1186/s12974-016-0720-6 – volume: 13 start-page: 279 issue: 1 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0021 article-title: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin publication-title: J. Neuroinflamm. doi: 10.1186/s12974-016-0717-1 – volume: 75 start-page: 65 issue: 1 year: 2018 ident: 10.1016/j.msard.2018.07.025_bib0013 article-title: Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs. aquaporin 4 IgG disease publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2017.3196 – volume: 87 start-page: 446 issue: 4 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0001 article-title: MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp-2014-310206 – volume: 77 start-page: 580 issue: 6 year: 2011 ident: 10.1016/j.msard.2018.07.025_bib0058 article-title: Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis publication-title: Neurology doi: 10.1212/WNL.0b013e318228c0b1 – volume: 22 start-page: 1541 issue: 12 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0018 article-title: Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case publication-title: Multiple Scler. doi: 10.1177/1352458515622986 – volume: 71 start-page: 276 issue: 3 year: 2014 ident: 10.1016/j.msard.2018.07.025_bib0033 article-title: Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2013.5857 – volume: 87 start-page: 1257 issue: 11 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0028 article-title: Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp-2015-312676 – volume: 70 start-page: 1375 issue: 11 year: 2013 ident: 10.1016/j.msard.2018.07.025_bib0032 article-title: Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2013.3890 – volume: 5 start-page: e412 issue: 1 year: 2018 ident: 10.1016/j.msard.2018.07.025_bib0052 article-title: Reversible paraspinal muscle hyperintensity in anti-MOG antibody-associated transverse myelitis publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000412 – volume: 2 start-page: e131 issue: 4 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0006 article-title: Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000131 – volume: 2 start-page: e62 issue: 1 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0077 article-title: Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000062 – volume: 90 start-page: 7990 issue: 17 year: 1993 ident: 10.1016/j.msard.2018.07.025_bib0056 article-title: Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.90.17.7990 – volume: 43 start-page: 631 issue: 11 year: 2005 ident: 10.1016/j.msard.2018.07.025_bib0053 article-title: Neuromyelitis optica publication-title: Spinal Cord doi: 10.1038/sj.sc.3101758 – volume: 89 start-page: 127 issue: 2 year: 2018 ident: 10.1016/j.msard.2018.07.025_bib0059 article-title: Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp-2017-316880 – volume: 3 start-page: e257 issue: 5 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0068 article-title: Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000257 – volume: 2 start-page: 295 issue: 3 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0069 article-title: Histopathology and clinical course of MOG-antibody-associated encephalomyelitis publication-title: Ann. Clin. Trans. Neurol. doi: 10.1002/acn3.164 – volume: 4 start-page: 202 issue: 4 year: 2008 ident: 10.1016/j.msard.2018.07.025_bib0019 article-title: Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica publication-title: Nat. Clin. Pract. Neurol. doi: 10.1038/ncpneuro0764 – volume: 66 start-page: 833 issue: 6 year: 2009 ident: 10.1016/j.msard.2018.07.025_bib0004 article-title: Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease publication-title: Ann. Neurol. doi: 10.1002/ana.21916 – volume: 20 start-page: 843 issue: 7 year: 2014 ident: 10.1016/j.msard.2018.07.025_bib0035 article-title: Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients publication-title: Multiple Scler. doi: 10.1177/1352458513507822 – volume: 23 start-page: 1377 issue: 10 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0045 article-title: Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders publication-title: Multiple Scler. doi: 10.1177/1352458516678474 – volume: 4 start-page: e322 issue: 2 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0049 article-title: MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy publication-title: Neurol. Neuroimmunol. Neuroinflamm. doi: 10.1212/NXI.0000000000000322 – volume: 140 start-page: 3128 issue: 12 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0026 article-title: Clinical presentation and prognosis in MOG-antibody disease: a UK study publication-title: Brain doi: 10.1093/brain/awx276 – volume: 20 start-page: 781 issue: 5 year: 2013 ident: 10.1016/j.msard.2018.07.025_bib0034 article-title: Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients publication-title: Eur. J. Neurol. doi: 10.1111/ene.12058 – volume: 125 start-page: 815 issue: 6 year: 2013 ident: 10.1016/j.msard.2018.07.025_bib0044 article-title: Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica publication-title: Acta Neuropathol. doi: 10.1007/s00401-013-1116-7 – volume: 59 start-page: 566 issue: 3 year: 2006 ident: 10.1016/j.msard.2018.07.025_bib0075 article-title: Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis publication-title: Ann. Neurol. doi: 10.1002/ana.20770 – volume: 72 start-page: 1 issue: 1 year: 1999 ident: 10.1016/j.msard.2018.07.025_bib0024 article-title: The structure and function of myelin oligodendrocyte glycoprotein publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1999.0720001.x – volume: 69 start-page: 752 issue: 6 year: 2012 ident: 10.1016/j.msard.2018.07.025_bib0063 article-title: Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis publication-title: Arch. Neurol. doi: 10.1001/archneurol.2011.2956 – volume: 13 start-page: 281 issue: 1 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0017 article-title: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: brainstem involvement - frequency, presentation and outcome publication-title: J. Neuroinflamm. doi: 10.1186/s12974-016-0719-z – volume: 19 start-page: 941 issue: 7 year: 2013 ident: 10.1016/j.msard.2018.07.025_bib0011 article-title: Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients publication-title: Multiple Scler. doi: 10.1177/1352458512466317 – volume: 264 start-page: 139 issue: 1 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0014 article-title: Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration publication-title: J. Neurol. doi: 10.1007/s00415-016-8333-7 – volume: 13 start-page: 211 issue: 2 year: 2007 ident: 10.1016/j.msard.2018.07.025_bib0047 article-title: Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein publication-title: Nat. Med. doi: 10.1038/nm1488 – volume: 87 start-page: 229 issue: 2 year: 2016 ident: 10.1016/j.msard.2018.07.025_bib0072 article-title: Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD publication-title: Neurology doi: 10.1212/WNL.0000000000002844 – volume: 39 start-page: 285 issue: 6 year: 2015 ident: 10.1016/j.msard.2018.07.025_bib0046 article-title: Anti-MOG (myelin oligodendrocyte glycoprotein)-positive severe optic neuritis with optic disc ischaemia and macular star publication-title: Neuroophthalmology doi: 10.3109/01658107.2015.1084332 – volume: 8 start-page: 529 year: 2017 ident: 10.1016/j.msard.2018.07.025_bib0055 article-title: Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.00529 – volume: 122 start-page: 2047 issue: Pt 11 year: 1999 ident: 10.1016/j.msard.2018.07.025_bib0062 article-title: Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study publication-title: Brain doi: 10.1093/brain/122.11.2047 – reference: 30384960 - Mult Scler Relat Disord. 2018 Oct;25:A1-A2 |
| SSID | ssj0000651461 |
| Score | 2.502199 |
| SecondaryResourceType | review_article |
| Snippet | •MOG antibody disease is the most recent antigen specific autoimmune disease on the NMO Spectrum.•MOG antibody disease is characterized by optic neuritis and... Highlights•MOG antibody disease is the most recent antigen specific autoimmune disease on the NMO Spectrum. •MOG antibody disease is characterized by optic... MOG antibody disease is an autoimmune disease of the central nervous system associated with a serological antibody against MOG, myelin oligodendrocyte... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 66 |
| SubjectTerms | Animals Autoantibodies - blood Humans Myelin-Oligodendrocyte Glycoprotein - immunology Neurology Neuromyelitis Optica - blood Neuromyelitis Optica - immunology |
| Title | MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2211034818302360 https://www.clinicalkey.es/playcontent/1-s2.0-S2211034818302360 https://dx.doi.org/10.1016/j.msard.2018.07.025 https://www.ncbi.nlm.nih.gov/pubmed/30048919 https://www.proquest.com/docview/2078582843 |
| Volume | 25 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VrYS4IN4sj8pIHAmb-JWE26qiLKAtB6jUmxU7trQVu1mRFqkXfjszjrNSRSkStySaiZPxeMaPmW8AXuMcofJtW2RCSZnJRvmsUaXL0Nd534ja1hF4fnmsFyfy06k63YPDMReGwiqT7R9serTW6cksSXO2Xa1mXzmtXSiPlCCshMZ1-z5Hb19NYH_-8fPieLfVgl6WqldTmTlOG4LIM-IPxUivdY-dQVFeVcTxpKrZ1_uov81Boy86ugd30ySSzYfvvA97fvMAbi_TMflDsMsvHxiKbGW79pKlM5h3bM6GRBXWBXaFAtWwG6K3fnoWES7Xl57i4nrWbWmzm8WEzB8Xa3pZROt8BCdH778dLrJUTCFzSvDzrM65b0tf2xACd6EIldWi9apoq0IoGxounOauFU3QDnvLWVEKnuMlikt4JR7DZNNt_FNgPKBP09q2Ia9kbRtbC4mU0irXNkK7KfBRfMYlpHEqePHdjCFlZybK3JDMTV4alPkU3uyYtgPQxs3kcuwXM-aQotUz6AhuZiuvY_N9Grm9KUzPTW7-0K4p6B3nFQX9d5OvRrUxOHTpPKbZ-O6iR6KyolNLKabwZNCn3a8TEFpVF_Wz_232OdyhuyHu8AVMUEf8S5w_ndsDuPX2V3GQRslv-SoZfQ |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRQIuiPLcAsVIHAm7sR0n4VZVLQt0y4FW6s2KX9JW7GZF2kq98NuZcZyVKtoicYsST5x8Hnv8mPkG4D3OESrvXJ6JQspMNoXPmqK0Gdo67xtRmzoSz8-O1PREfj0tTjdgb4iFIbfKNPb3Y3ocrdOdcUJzvJrPxz84rV0ojpQorITCdfs9SWkOUKk__s7XGy1oYyl3NSWZ47QdiBID-1D081p02BTk41VFFk_KmX2zhbptBhot0cFjeJSmkGy3_8ot2PDLJ3B_lg7Jn4KZff_MELC5ad0VSycwn9gu68NUWBvYtRKohG3vu3XpWeS3XFx58orrWLuirW4WwzF_XSzoZZGr8xmcHOwf702zlEohswjJeVZPuHelr00IgduQh8oo4XyRuyoXhQkNF1Zx60QTlMW2skaUCCVeIlzCF-I5bC7bpX8JjAe0aEoZFyaVrE1jaiGxpDSFdY1QdgR8gE_bxDNO6S5-6sGh7ExHzDVhrielRsxH8GEttOppNu4uLod20UMEKY55Gs3A3WLlTWK-S_2207nuuJ7ov3RrBGoteU09_13lu0FtNHZcOo1plr696LBQWdGZpRQjeNHr0_rXiQatqvN6-3-rfQsPpsezQ3345ejbK3hIT3oPxNewifri3-BM6tzsxJ7yB0JuGj8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MOG+antibody+disease%3A+A+review+of+MOG+antibody+seropositive+neuromyelitis+optica+spectrum+disorder&rft.jtitle=Multiple+sclerosis+and+related+disorders&rft.au=Narayan%2C+Ram&rft.au=Simpson%2C+Alexandra&rft.au=Fritsche%2C+Katelyn&rft.au=Salama%2C+Sara&rft.date=2018-10-01&rft.issn=2211-0348&rft.volume=25&rft.spage=66&rft.epage=72&rft_id=info:doi/10.1016%2Fj.msard.2018.07.025&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_msard_2018_07_025 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-0348&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-0348&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-0348&client=summon |